tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Iovance Biotherapeutics’ Canadian Approval of AMTAGVI: A Milestone in T Cell Therapy and Stock Growth Potential
PremiumRatingsIovance Biotherapeutics’ Canadian Approval of AMTAGVI: A Milestone in T Cell Therapy and Stock Growth Potential
2M ago
Iovance Amtagvi receives Health Canada approval for advanced melanoma
Premium
The Fly
Iovance Amtagvi receives Health Canada approval for advanced melanoma
2M ago
Iovance Biotherapeutics’ Earnings Call Highlights Growth
Premium
Company Announcements
Iovance Biotherapeutics’ Earnings Call Highlights Growth
2M ago
Iovance Biotherapeutics Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsIovance Biotherapeutics Reports Q2 2025 Financial Results
2M ago
Iovance Biotherapeutics reports Q2 EPS (33c), consensus 928c)
Premium
The Fly
Iovance Biotherapeutics reports Q2 EPS (33c), consensus 928c)
2M ago
Iovance Biotherapeutics backs FY25 revenue view $250M-$200M, consensus $287.11M
Premium
The Fly
Iovance Biotherapeutics backs FY25 revenue view $250M-$200M, consensus $287.11M
2M ago
Realty Income, GitLab, DoorDash, Iovance, Senseonics: Trending by Analysts
PremiumWeekend UpdatesRealty Income, GitLab, DoorDash, Iovance, Senseonics: Trending by Analysts
3M ago
Iovance Biotherapeutics Appoints New Chief Financial Officer
Premium
Company Announcements
Iovance Biotherapeutics Appoints New Chief Financial Officer
3M ago
Iovance Biotherapeutics appoints Roche as CFO
Premium
The Fly
Iovance Biotherapeutics appoints Roche as CFO
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100